Cellular trafficking determines the exon skipping activity of Pip6a-PMO in mdx skeletal and cardiac muscle cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cellular trafficking determines the exon skipping activity of Pip6a-PMO in mdx skeletal and cardiac muscle cells
Authors
Keywords
-
Journal
NUCLEIC ACIDS RESEARCH
Volume 42, Issue 5, Pages 3207-3217
Publisher
Oxford University Press (OUP)
Online
2013-12-24
DOI
10.1093/nar/gkt1220
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of Cell-Penetrating-Peptides in Oligonucleotide Splice Switching Therapy
- (2012) Samir A. El Andaloussi et al. CURRENT GENE THERAPY
- Gene therapy for Duchenne muscular dystrophy
- (2012) Ingrid E.C. Verhaart et al. CURRENT OPINION IN NEUROLOGY
- Cell-penetrating peptides for the delivery of nucleic acids
- (2012) Taavi Lehto et al. Expert Opinion on Drug Delivery
- Genetic Therapeutic Approaches for Duchenne Muscular Dystrophy
- (2012) Helen Foster et al. HUMAN GENE THERAPY
- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
- (2011) Sebahattin Cirak et al. LANCET
- Pip5 Transduction Peptides Direct High Efficiency Oligonucleotide-mediated Dystrophin Exon Skipping in Heart and Phenotypic Correction in mdx Mice
- (2011) HaiFang Yin et al. MOLECULAR THERAPY
- Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
- (2011) Nathalie M. Goemans et al. NEW ENGLAND JOURNAL OF MEDICINE
- In vitroevaluation of novel antisense oligonucleotides is predictive ofin vivoexon skipping activity for Duchenne muscular dystrophy
- (2010) Qingsong Wang et al. JOURNAL OF GENE MEDICINE
- Chronic Systemic Therapy With Low-dose Morpholino Oligomers Ameliorates the Pathology and Normalizes Locomotor Behavior in mdx Mice
- (2010) Alberto Malerba et al. MOLECULAR THERAPY
- Efficacy of systemic morpholino exon-skipping in duchenne dystrophy dogs
- (2009) Toshifumi Yokota et al. ANNALS OF NEUROLOGY
- Cell penetrating peptides: overview and applications to the delivery of oligonucleotides
- (2009) F. Said Hassane et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino
- (2009) B Wu et al. GENE THERAPY
- Dosing Regimen Has a Significant Impact on the Efficiency of Morpholino Oligomer-Induced Exon Skipping in mdx Mice
- (2009) Alberto Malerba et al. HUMAN GENE THERAPY
- Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
- (2009) Maria Kinali et al. LANCET NEUROLOGY
- Prevention of Dystrophic Pathology in Severely Affected Dystrophin/Utrophin-deficient Mice by Morpholino-oligomer-mediated Exon-skipping
- (2009) Aurélie Goyenvalle et al. MOLECULAR THERAPY
- Sustained Dystrophin Expression Induced by Peptide-conjugated Morpholino Oligomers in the Muscles of mdx Mice
- (2008) Natee Jearawiriyapaisarn et al. MOLECULAR THERAPY
- Improved cell-penetrating peptide–PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle
- (2008) Gabriela D. Ivanova et al. NUCLEIC ACIDS RESEARCH
- Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer
- (2008) B. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now